Alpha Capital Anstalt 13D/13G Filings for Qualigen Therapeutics, Inc. (QLGN)

Alpha Capital Anstalt 13D and 13G filings for Qualigen Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-11-12
5:17 pm
Purchase
2025-09-3013GQualigen Therapeutics, Inc.
QLGN
Alpha Capital Anstalt153,545
9.056%
153,545increase
(New Position)
Filing